0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover1030.30%IV-350.45%PremiumDec 20, 2024Expiry Date3.89Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7626Delta0.2404Gamma0.28Leverage Ratio-0.0412Theta-0.0005Rho-0.21Eff Leverage0.0004Vega
LAVA Therapeutics Stock Discussion
📊⚡️📊
LAVA Therapeutics N.V., a leader in the biotechnology sector, has recently announced a significant clinical development milestone achieved by Pfizer for the drug PF-08046052. This milestone has prompted the first payment of $7 million to LAVA, marking a notable event in the field of immuno-oncology. $LAVA Therapeutics (LVTX.US)$
https://stockregion.app/p/biotech-leader-announces-7m-milestone
No comment yet